Skip to content

Evaluation of Nutrition and Metabolism in Breast Cancer Patients

Evaluation of Nutrition and Metabolism in Breast Cancer Patients

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01542216
Enrollment
0
Registered
2012-03-02
Start date
2012-02-29
Completion date
2015-09-30
Last updated
2015-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

With the increased success in breast cancer therapies, survivors develop unhealthy changes in body composition, such as muscle loss and fat gains, which lead to increased risk of cardiovascular disease and diabetes in survivorship. This study will examine the effects of a nutrition, cardiovascular and strength exercise program compared with a yoga program (representing usual care) on body composition and metabolism in recently diagnosed breast cancer patients. Nutrition and exercise may improve various body composition and metabolic parameters, which may improve quality of life in survivorship, reduce risk of recurrence and reduce the risk of developing cardiovascular disease and diabetes in survivorship.

Detailed description

Despite the increased success of novel anti-neoplastic therapies, breast cancer patients receiving chemotherapy develop unfavourable changes in body composition, including lean tissue loss and fat gains (1,2). These detrimental changes associate with poor quality of life (3,4) and may lead to treatment complications (5,6) during the cancer trajectory. In non-malignant populations, fat gain and muscle loss associate with increased risk of cardiovascular disease and diabetes (7). Cancer survivors who gain fat and lose lean mass are not only predisposed to these diseases but also have an increased risk of cancer recurrence (3). Proper nutrition as well as exercise can independently improve metabolic profiles (i.e. immune function, lipid and glucose metabolism) and overall health outcomes in non-malignant populations (7-9). While exercise has enhanced quality of life in breast cancer patients (4), overall nutritional needs and the metabolic benefits of exercise are unclear in this patient group. Understanding the effects of nutrition and exercise interventions in breast cancer patients will form the basis for future studies and programs that integrate nutrition, exercise, and metabolism to reduce cancer recurrence and other morbidities in survivorship. This study will examine the effects of nutrition and exercise intervention on body composition and metabolism in recently diagnosed breast cancer patients.

Interventions

BEHAVIORALNutrition and Exercise Group

Patients randomized to this arm will receive nutrition and exercise consultations. Exercise consultations will home- and institution-based.

BEHAVIORALYoga and Stretching Group

Patients randomized to this arm will receive consultations on yoga and stretching exercises.

Sponsors

Grand River Regional Cancer Centre
CollaboratorOTHER
University of Waterloo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Females 18 years old or older * Recent diagnosis of breast cancer and up to 4 weeks following the first cycle of chemotherapy or up to the first 4 weeks of radiation therapy * Clinical Stages I-IIIa * Able to communicate freely in English * Have sufficient cognitive ability to participate and provide informed consent

Exclusion criteria

* Any known diagnosis of cardiovascular disease and thyroid disease that is not currently managed with medication or other therapies * Any known diagnosis of diabetes or HIV * Pre-existing injuries or health conditions that prevents the patient's safe participation in exercise * Any previous diagnosis of cancer within the last 5 years (other than carcinoma in situ) * Fasting glucose \>7.0 mM at baseline of the study * Pregnant individuals will be excluded from this study

Design outcomes

Primary

MeasureTime frameDescription
Change in glucose parameters from baselineBaseline, 8 weeks, 16 weeksOral glucose tolerance tests will be performed at each assessment. Changes from baseline will be measured.

Secondary

MeasureTime frame
Change in lipid profile relative to baselineBaseline, 8 weeks, 16 weeks

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026